Affiliations 

  • 1 University of Liverpool, Women and Children's Health, Liverpool, United Kingdom; Southport and Ormskirk NHS Trust, Southport, United Kingdom. Electronic address: may.ng@nhs.net
  • 2 Kantha Bopha Children's Hospital, Phnom Penh, Cambodia
  • 3 Mandalay Children's Hospital, Mandalay, Myanmar
  • 4 Mahosot Hospital, Vientiane, Lao People's Democratic Republic
  • 5 Vietnam National Children's Hospital, Hanoi, Viet Nam
  • 6 Sarawak General Hospital, Kuching, Malaysia
  • 7 University Malaya, Kuala Lumpur, Malaysia
  • 8 Action 4 Diabetes, Somerset, United Kingdom
  • 9 KK Women's and Children's Hospital, Singapore, Singapore
Diabetes Res Clin Pract, 2022 May;187:109868.
PMID: 35395247 DOI: 10.1016/j.diabres.2022.109868

Abstract

This will be the first publication of Type 1 diabetes(T1D) outcomes in five low-middle-income countries (LMICs)-Laos, Malaysia, Vietnam, Cambodia and Myanmar in the Southeast Asia (SEA) region. The information obtained has been possible due to partnership programmes of non-government organisationAction4Diabetes (A4D) with defined local hospitalsthrough a Memorandum of Understandingsigned with the governments in SEAthat guarantees ongoing supplies of free insulin, blood glucose meter supplies, HbA1c tests and hospital emergency funds.

PARTICIPANTS: Between 2020 and 2021, 383 children and young people with T1D who were active in the A4D supported programmes were reviewed including information on health coverage, multidisciplinary team management, diabetic ketoacidosis (DKA) on admission and insulin regimen.

RESULTS: Mean HbA1c between 2020 and 2021 for patients in these LMICs arereported for the first time. The average glycaemic index in the five SEAcountries reviewed between 2020 and 2021 were high at 83 mmol/mol (9.7%).

CONCLUSIONS: Government partnership working with non-government organisationsto support T1D from diagnosis to adulthood are the first steps to closing thegaps in many LMICs. Further epidemiological studies are needed to identify the glycaemic outcomes and DKA rates on admission for many of these countries.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.